oral noncovalent hemoglobin (HbS) modulator

2:1 binding, high RBC partition.; in Ph. I w/ HV

from virtual screening, NMR confirm. and opt.

J. Med. Chem., Dec. 24, 2020

Pfizer, Groton, CT / Cambridge, MA

Pfizer noncovalent oral hemoglobin (HbS) modulator


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks